Sector
Healthcare M&A activity spans pharmaceuticals, biotechnology, medical devices, and healthcare services. The sector attracts both strategic consolidators seeking scale and private equity investors focused on platform building in specialized segments.
Columna Capital has exited Swiss dental platform Ardentis Cliniques Dentaires in an undisclosed transaction, selling a majority stake to Medbase. The deal extends consolidation momentum in French-speaking Switzerland’s dental market.
UK healthcare company Mironid has secured EUR 55.42 million in funding from a syndicate including the Scottish National Investment Bank and Roche Venture Fund to advance a therapy for rare kidney disease.
Wise Equity has announced a majority acquisition of E-Pharma Trento, an Italian CDMO with two Trento facilities. The deal underlines sustained PE appetite for outsourced pharma manufacturing, despite early reporting confusion on the target’s geography.
TA Associates has ended its takeover interest in UK-listed Advanced Medical Solutions, pushing shares lower. Deal terms were never disclosed, leaving investors to reassess standalone prospects and optionality.
Danish healthcare startup Alcolase has raised EUR 1.5 million in a funding round backed by Ada Ventures, Delphinus Venture Capital, Antler, Manigoff Invest and angel investors.
PolyPeptide Group has shortlisted EQT and IDG Capital as its sale process moves forward, according to Private Equity Wire. Financial terms have not been disclosed.
Danish healthcare startup Alcolase has raised EUR 1.5 million from Ada Ventures, Delphinus Venture Capital, Antler, Manigoff Invest and business angels. The round backs development of an enzyme-based solution targeting alcohol intolerance.
HIG Capital-backed Avanta Salud has agreed to acquire Spain-based Vitaly Group in an undisclosed transaction, adding scale in healthcare services.
Miura Partners has acquired Italy-based Medcomp in an undisclosed deal, adding a Milan platform in medical device distribution. Deal terms and integration plans have not been disclosed.
Bain Capital Private Equity has agreed to acquire Fabbrica Italiana Sintetici (FIS), an Italian healthcare manufacturer. Financial terms were not disclosed.
Five Arrows-backed Biophorum has acquired UK-based PharmaX Solutions for an undisclosed amount. The deal extends Biophorum’s services footprint across the biopharma operating model.
UK-based Cytospire Therapeutics has secured EUR 73.49 million in funding from a broad syndicate including 4BIO Capital, Servier Ventures and Abingworth to advance its oncology programme.
Amulet Capital has agreed to acquire UK-based TFP Fertility Group from Benefit Street Partners. Financial terms were not disclosed.
Finnish healthtech Oura Health has announced a EUR 833.33 million funding round. The investor group and deal terms were not disclosed.
Baird Capital has provided undisclosed funding to healthcare consulting firm Blue Matter. Deal terms and use of proceeds were not disclosed.
Sweden-based healthcare company Moleculent has secured EUR 18.52 million in funding from Rubicon Healthcare Partners, ARCH Venture Partners and Eir Ventures. Terms and use of proceeds were not disclosed.
Danish healthcare company Hemab Therapeutics has announced the pricing of an upsized initial public offering totaling EUR 279.17 million. The company has not disclosed investor identities in the announcement cited.
The Equity Club has invested in Italian healthcare platform Brexia Med in an undisclosed funding round. Deal terms and the use of proceeds were not disclosed.
French digital rehabilitation platform Axomove has secured EUR 4 million in funding from Digital Prevention Fund, Go Capital, Inco Ventures and Faraday Venture Partners.
UK healthcare technology company Cerca Magnetics has raised EUR 4.3 million in funding from Guinness Ventures. The round targets scaling of wearable brain imaging systems powered by quantum sensing.